2min chapter

Huberman Lab cover image

How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks

Huberman Lab

CHAPTER

Psychedelics: A Therapeutic Frontier for Depression and Addiction

Psilocybin received what's called breakthrough status at the FDA about five years ago. There are now a lot of clinical trials exploring how psilocybin can impact various things like mood disorders, addictive disorders and so on. This episode goes in depth into these clinical studies and what those studies really look like.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode